NIH-funded research NIH-funded research

Understanding how cannabis use and genes change the brain to increase depression risk

Official title: Functional convergence following disruption of diverse genes associated with cannabis use and major depression

Funded at Yale University · NIH-11395269 · Data updated 2026-11-12

A research project at Yale is exploring how cannabis use might change specific brain cells and genes, potentially making people more vulnerable to depression.

More Depression research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 1, 2024
Project endJuly 31, 2029
Funding year2026
Award (this year)$441,000
NIH project number5DP1DA060811-03
Project IDNIH-11395269 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with cannabis use disorder, with or without major depressive disorder, or neurotypical controls, from whom brain tissue or related data can be analyzed.

Less likely to help

People without access to brain tissue data or related analyses are unlikely to directly benefit from this study.

What this research studies

Researchers will study postmortem brain tissue from donors with cannabis use disorder, depression, and controls to map cell-type-specific genetic and epigenetic changes in two brain regions. They will connect these molecular changes to signals that relate to depression risk and use human iPSC-derived brain organoids to test the function of candidate genes. The study combines single-cell genomics with targeted genetic approaches to link cannabis-associated genetic signals to brain biology relevant to mood disorders. By focusing on the dorsolateral prefrontal cortex and ventral striatum, the project aims to identify mechanisms that could be targeted for future therapies. The work is exploratory but designed to build a foundation for understanding how cannabis exposure may influence the development of major depressive disorder at the cellular level.

Why it matters

Potential benefit: This research could identify molecular targets that inform new treatments or prevention strategies for depression linked to cannabis use.

How similar studies have gone: Previous work shows links between cannabis exposure and brain changes, but this project seeks to connect those changes to specific cells and genes in humans.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Girgenti, Matthew J — Yale University
  • Study coordinator: Girgenti, Matthew J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.